Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: A single-center, retrospective, observational study

American Journal Geriatric Pharmacotherapy

Volumn 7, Issue 3, 2009, Pages 159-166

  Jacobs, Laurie G ^a   Billett, Henny H ^a   Freeman, Katherine ^a   Dinglas, Cheryl ^b   Jumaquio, Lynette ^c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NEW YORK INSTITUTE OF TECHNOLOGY   (United States)

^c ReGenesis Community Health Center   (United States)

Author keywords

atrial fibrillation; dementia; elderly; falls; warfarin

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEMENTIA; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FALLING; FEMALE; GERIATRIC PATIENT; HEART ATRIUM FIBRILLATION; HIGH RISK PATIENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PRESCRIPTION; PRIMARY PREVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; SECONDARY PREVENTION;

ACCIDENTAL FALLS; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ASPIRIN; ATRIAL FIBRILLATION; DEMENTIA; FEMALE; FIBRINOLYTIC AGENTS; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; WARFARIN;

EID: 67650225256     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2009.06.002     Document Type: Article

References (27)

1. Wolf P.A., Abbott R.D., and Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 22 (1991) 983-988
2. Hart R.G., Pearce L.A., and Aguilar M.I. Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation. Ann Intern Med 147 (2007) 590-592
3. Singer D.E., Albers G.W., Dalen J.E., et al., the American College of Chest Physicians. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 133 Suppl 6 (2008) 546S-592S
4. Mant J., Hobbs F.D., Fletcher K., et al., the BAFTA Investigators and the Midland Research Practices Network (MidReC). Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): A randomised controlled trial. Lancet 370 (2007) 493-503
5. Fang M.C., Stafford R.S., Ruskin J.N., and Singer D.E. National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation. Arch Intern Med 164 (2004) 55-60
6. Go A.S., Hylek E.M., Chang Y., et al. Anticoagulation therapy for stroke prevention in atrial fibrillation: How well do randomized trials translate into clinical practice?. JAMA 290 (2003) 2685-2692
7. Gross C.P., Vogel E.W., Dhond A.J., et al. Factors influencing physicians' reported use of anticoagulation therapy in nonvalvular atrial fibrillation: A cross-sectional study. Clin Ther 25 (2003) 1750-1764
8. Hylek E.M., D'Antonio J., Evans-Molina C., et al. Translating the results of randomized trials into clinical practice: The challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation. Stroke 37 (2006) 1075-1080
9. Hylek E.M., Evans-Molina C., Shea C., et al. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 115 (2007) 2689-2696
10. Folstein M.F., Robins L.N., and Helzer J.E. The Mini-Mental State Examination. Arch Gen Psychiatry 40 (1983) 812
11. Gage B.F., Waterman A.D., Shannon W., et al. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 285 (2001) 2864-2870
12. Beyth R.J., Quinn L.M., and Landefeld C.S. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med 105 (1998) 91-99
13. Rosendaal F.R., Cannegieter S.C., van der Meer F.J., and Briët E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 69 (1993) 236-239
14. Olsen T.S., Rasmussen B.H., Kammersgaard L.P., and Germer U. Strokes attributable to underuse of warfarin and antiplatelets. J Stroke Cerebrovasc Dis 14 (2005) 55-57
15. Rose A.J., Ozonoff A., Henault L.E., and Hylek E.M. Warfarin for atrial fibrillation in community-based practise. J Thromb Haemost 6 (2008) 1647-1654
16. Kent D.L., Vermes D., McDonell M., et al., the Warfarin Optimal Outpatient Follow-up Study Group. A model for planning optimal follow-up for outpatients on warfarin anticoagulation. Med Decis Making 12 (1992) 132-141
17. Pengo V., Barbero F., Biasiolo A., et al. A comparison between six- and four-week intervals in surveillance of oral anticoagulant treatment. Am J Clin Pathol 120 (2003) 944-947
18. Tinetti M.E., Speechley M., and Ginter S.F. Risk factors for falls among elderly persons living in the community. N Engl J Med 319 (1988) 1701-1707
19. Gage B.F., Birman-Deych E., Kerzner R., et al. Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall. Am J Med 118 (2005) 612-617
20. Pengo V. Long-term warfarin use to prevent both stroke and dementia in subjects with atrial fibrillation?. J Thromb Haemost 2 (2004) 1871-1872
21. Barber M., Tait R.C., Scott J., et al. Dementia in subjects with atrial fibrillation: Hemostatic function and the role of anticoagulation. J Thromb Haemost 2 (2004) 1873-1878
22. O'Connell J., Gray C., French J., and Robertson I. Atrial fibrillation and cognitive function: Case-control study. J Neurol Neurosurg Psychiatry 65 (1998) 386-389
23. Kilander L., Andrén B., Nyman H., et al. Atrial fibrillation is an independent determinant of cognitive function: A cross-sectional study in elderly men. Stroke 29 (1998) 1816-1820
24. Barba R., Martínez-Espinosa S., Rodríguez-García E., et al. Post-stroke dementia: Clinical features and risk factors. Stoke 31 (2000) 1494-1501
25. Zhou D.H., Wang J.Y., Li J., et al. Study on frequency and predictors of dementia after ischemic stroke: The Chongqing stroke study. J Neurol 251 (2004) 421-427
26. Rastas S., Verkkoniemi A., Polvikoski T., et al. Atrial fibrillation, stroke, and cognition: A longitudinal population-based study of people aged 85 and older. Stroke 38 (2007) 1454-1460
27. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials [published correction appears in Arch Intern Med. 1994;154;2254]. Arch Intern Med 154 (1994) 1449-1457